AI phone app aims to ease cancer treatment side effects
NCT ID NCT07553572
First seen Apr 29, 2026 · Last updated Jun 20, 2026 · Updated 8 times
Summary
This pilot study is testing whether a smartphone app called ASSIST can help people with breast, colorectal, or lymphoma cancer manage symptoms while receiving systemic therapy. The app uses artificial intelligence to offer personalized support. The main goals are to see if patients find the app easy to use and if they like it. Sixty participants will be randomly assigned to use the app plus standard care, or just standard care, and will complete surveys over 12 weeks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LYMPHOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Massachusetts General Hospital
RECRUITINGBoston, Massachusetts, 02114, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
ASSIST smartphone application (AI-based symptom management tool)
What this could lead to
If successful, this could provide a new way for cancer patients to manage symptoms at home using a smartphone app, potentially improving quality of life during treatment.
What could go wrong
This is a very early pilot study with only 60 participants, focused on feasibility and acceptability, not on health outcomes. The app may not be helpful for everyone, and results may not apply to all cancer types.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.